Untapped Potential? Representativeness in Pragmatic Clinical Trials

This JAMA Viewpoint explores the potential of pragmatic clinical trials to improve demographic representativeness and health equity in clinical research.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2024-11-20
DOI
https://doi.org/10.1001/jama.2024.22983
Citations
6
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
6.78
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Untapped Potential? Representativeness in Pragmatic Clinical Trials

Stephanie R. Morain, Caleigh Propes, Kayla Mehl
6 citations
JAMA
Health Systems, Economic Evaluations, Quality of Life
6.78
article

Untapped Potential? Representativeness in Pragmatic Clinical Trials

Stephanie R. Morain, Caleigh Propes, Kayla Mehl
article en
6 citations

Abstract

This JAMA Viewpoint explores the potential of pragmatic clinical trials to improve demographic representativeness and health equity in clinical research.

JAMAVol. 333(5)
Johns Hopkins University (US), Johns Hopkins Berman Institute of Bioethics (US)
Openalex Percentile: Top 3%
Health Systems, Economic Evaluations, Quality of Life
6.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Untapped Potential? Representativeness in Pragmatic Clinical Trials — Stephanie R. Morain, Caleigh Propes, et al. · JAMA (2024) | TGRS Research Map | TGRS